Log In
Print
BCIQ
Print
Print this Print this
 

Urine-Based K-Ras (KRAS) Oncogene Mutation Assay

Also known as: cf-KRAS, Transrenal KRAS test

  Manage Alerts
Collapse Summary General Information
Company Trovagene Inc.
DescriptionMolecular diagnostic test to detect KRAS mutations from cell-free (cf) DNA in urine
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect KRAS mutations in colorectal cancer; Monitor metastatic colorectal cancer (mCRC) in patients undergoing therapy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today